Pre-Open Movers 02/03: (INSM) (AIMT) (GILD) Higher; (NKTR) (CHKP) (NOC) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Aimmune Therapeutics (AIMT) Reports Licensing of Exclusive Worldwide Rights to Xencor (XNCR) XmAb7195 for Development of Next-Generation Food Allergy Treatments
February 5, 2020 8:08 AM ESTAimmune Therapeutics, Inc. (NASDAQ: AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced it has obtained an exclusive worldwide license to develop and commercialize the investigational humanized monoclonal antibody XmAb®7195 from Xencor, Inc. (NASDAQ: XNCR).
XmAb7195, which has been renamed AIMab7195, was originally developed by Xencor for the treatment of allergic asthma. It uses three distinct mechanisms of action to reduce blood serum IgE and suppress IgE-producing cells. Aimmune initially plans to develop AIMab7195 as an adjunctive treatment with select Characterized Oral Desensitized... More
Taylor Morrison Home (TMHC) Tops Q4 EPS by 5c, Revenues Beat
February 5, 2020 6:58 AM ESTTaylor Morrison Home (NYSE: TMHC) reported Q4 EPS of $1.06, $0.05 better than the analyst estimate of $1.01. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.43 billion.
Fiscal Year 2019 Highlights:
Net sales orders were 10,517, a 25 percent increase over the prior yearAverage monthly sales pace per community was 2.5, compared to 2.3 for 2018Home closings were 9,964, an almost 14 percent increase over the prior yearTotal revenue was $4.8 billion, a 13 percent increase over the prior yearHome closings gross margin adjusted for unusual items was 18.2 percent, while GAAP home... More